Dr. David Simon, MD – Boston, MA
By James Craig
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
FS-ZONE Investigators (Simon DK), Lancet Neurology, 1/1/2015Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone effects
Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B, on behalf of the NET-PD FS-Zone I..., J Parkinson’s Dis, 1/1/2015No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial
Umeh CC, Perez A, Augustine EF, Dhall R, Dewey RB, Mari Z, Simon DK, Wills AA, Christine CW, Schneider JS, Suchowersky O, PLoS ONE, 1/1/2014
